Cargando…
Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
BACKGROUND: Statins may be protective in severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection. The aim of the current study was to evaluate the effect of in-hospital statin use on 28-day mortality rates and intensive care unit (ICU) admission among patients with SARS-CoV-2, stratifie...
Autores principales: | Memel, Zoe N, Lee, Jenny J, Foulkes, Andrea S, Chung, Raymond T, Thaweethai, Tanayott, Bloom, Patricia P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586726/ https://www.ncbi.nlm.nih.gov/pubmed/34665852 http://dx.doi.org/10.1093/infdis/jiab539 |
Ejemplares similares
-
Statins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection
por: Memel, Zoe N., et al.
Publicado: (2021) -
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality
por: Olender, Susan A, et al.
Publicado: (2021) -
Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis
por: Yetmar, Zachary A, et al.
Publicado: (2021) -
Aspirin with or without statin in the treatment of endotheliitis, thrombosis, and ischemia in coronavirus disease
por: Florêncio, Francisco Kleyton Zacarias, et al.
Publicado: (2020) -
Body composition predictors of outcome in patients with COVID-19
por: Bunnell, Katherine M., et al.
Publicado: (2021)